Table 2.

Dose of CAF Effect in the Analyzed Subset (n = 624)

Characteristic	Dose of CAF			P
	Low	Moderate	High
Age, years
Median	51	50	49	.62
Range	22-76	26-75	29-77
Tumor size, cm
Median	3.0	3.0	2.5	.24
Range	0.4-11.5	0.5-12.0	0.3-9.5
No. of positive nodes
Median	3.0	3.0	3.0	.83
Range	1-29	1-54	1-38
Premenopausal, %	39	43	38	.58
Receptor positive, %	74	70	73	.64

NOTE. Age, tumor size, and No. of positive nodes were compared using the Kruskal–Wallis test. The χ² test was used to test for differences in percentage premenopausal and receptor positive.

Abbreviation: CAF, cyclophosphamide, doxorubicin, and fluorouracil.